B

Bangkok Lab and Cosmetic PCL
SET:BLC

Watchlist Manager
Bangkok Lab and Cosmetic PCL
SET:BLC
Watchlist
Price: 5 THB -2.91% Market Closed
Market Cap: 3B THB
Have any thoughts about
Bangkok Lab and Cosmetic PCL?
Write Note

Operating Margin
Bangkok Lab and Cosmetic PCL

14.7%
Current
14%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.7%
=
Operating Profit
225.4m
/
Revenue
1.5B

Operating Margin Across Competitors

Country TH
Market Cap 3B THB
Operating Margin
15%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 744.2B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.3T DKK
Operating Margin
44%
Country US
Market Cap 373.9B USD
Operating Margin
28%
Country US
Market Cap 258.4B USD
Operating Margin
34%
Country CH
Market Cap 200.6B CHF
Operating Margin
32%
Country UK
Market Cap 161.8B GBP
Operating Margin
21%
Country CH
Market Cap 180.7B CHF
Operating Margin
31%
Country US
Market Cap 146.9B USD
Operating Margin
22%
No Stocks Found

Bangkok Lab and Cosmetic PCL
Glance View

Market Cap
3B THB
Industry
Pharmaceuticals

Bangkok Lab & Cosmetic PCL engaes in the provision of pharmaceuticals and health products. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2023-06-21. The firm is engaged in the production of medicines and health products by selecting raw materials. The firm has produced more than 100 products. Its products include ZENZERA 200 SUSPENSION, ZENZERA, SYNOVAR UC40, RADIARA, PROCEMINE, FANGO-B, EMBLICOF COUGH MIXTURE, CLINIGEL STERILE, RAQUA FIBROTA, RAQUA COLLAGEN, SYNOVAR UC, SYNOVAR POWDER, NACOXIB, LUTI-BERRY MIXED, ZIGA GEL (orange), ZERTINE SYRUP, VIZO Cream, SPORAXYL CREAM, NORAPHEN, MURHINOL-250 SYRUP, NORFLOXYL 400, NOCID, MURHINOL-250 SYRUP, MUCOBROX, GYNOSTEN CREAM, and GYNOSTEN 500, AROTIKA COOL GEL, ALLERAX-FC, AROTIKA RUB LOTION (SPRAY), Calza c Dietary Supplement, Calza PLUS POWDER Dietary, and Calza-750 TAB FC, among others. Its products are distributed through Bangkok Drug Co., Ltd., Beereach (Thailand) Co., Ltd., Pharmaline Company Limited, Pharma Alliance Company Ltd., and Bangkok Medica Co., Ltd.

BLC Intrinsic Value
3.88 THB
Overvaluation 22%
Intrinsic Value
Price
B

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
14.7%
=
Operating Profit
225.4m
/
Revenue
1.5B
What is the Operating Margin of Bangkok Lab and Cosmetic PCL?

Based on Bangkok Lab and Cosmetic PCL's most recent financial statements, the company has Operating Margin of 14.7%.